Showing results (211-220 of 225) with videos related to
Sort By:
Pageof 23
Molecular Psychiatry|March 24, 2004
Binge-eating episodes are not characteristic of carriers of melanocortin-4 receptor gene mutationsJ Hebebrand, F Geller, A Dempfle, et al.The Journal of Infectious Diseases|July 23, 2002
The pharmacokinetics of amprenavir, zidovudine, and lamivudine in the genital tracts of men infected with human immunodeficiency virus type 1 (AIDS clinical trials group study 850)Arlene S Pereira, Laura M Smeaton, John G Gerber, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2007
Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186John G Gerber, Douglas W Kitch, Carl J Fichtenbaum, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 20, 2002
Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panelMorris Schambelan, Constance A Benson, Andrew Carr, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 6, 2009
Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavirDavid W Haas, Susan L Koletar, Laura Laughlin, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 16, 2004
Comparison of two indinavir/ritonavir regimens in the treatment of HIV-infected individualsEdward P Acosta, Hulin Wu, Scott M Hammer, et al.The Journal of Infectious Diseases|February 22, 2001
Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS Clinical Trials Group protocol 373R M Gulick, L M Smeaton, R T D'Aquila, et al.Brachytherapy|January 13, 2026
MRI-guided neurovascular bundle avoidance in high dose rate prostate brachytherapyDrew G Gerber, Sean Dresser, Xiaofeng Yang, et al.HIV Clinical Trials|January 18, 2011
A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimenScott M Hammer, Heather Ribaudo, Roland Bassett, et al.The Journal of Infectious Diseases|March 9, 1999
Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study TeamR L Murphy, R M Gulick, V DeGruttola, et al.Pageof 23